Fasikl
Fasikl Inc. is a neuro-AI company developing AI-supported neural technologies. It is a spin-off from the University of Minnesota, founded in 2019. Fasikl’s products harness their proprietary technology that acquires neural signals from nerves to inform AI-driven therapy. Their mission is to propel progress in neurotherapies, pioneering treatments that make a profound difference in the wellbeing of the patients they serve.
Funding
Every round, secondary, debt facility or acquisition involving Fasikl that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in